Basecamp Wealth Advisors’s First Tracks Biotherapeutics TRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAX
Basecamp Wealth Advisors's TRAX Position: Q3 2026 in Review
Basecamp Wealth Advisors opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 104 shares worth $3.69K. The stake represents ﹤0.01% of the portfolio and ranks #1195 among its holdings.
182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.
- Basecamp Wealth Advisors held 104 shares of First Tracks Biotherapeutics worth $3.69K as of Q3 2026.
- First Tracks Biotherapeutics was a new Basecamp Wealth Advisors position in Q3 2026.
- First Tracks Biotherapeutics made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q3 2026, its #1195 holding.
- 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.
Based on Basecamp Wealth Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.